MX2022003230A - Composiciones antitranspirantes. - Google Patents

Composiciones antitranspirantes.

Info

Publication number
MX2022003230A
MX2022003230A MX2022003230A MX2022003230A MX2022003230A MX 2022003230 A MX2022003230 A MX 2022003230A MX 2022003230 A MX2022003230 A MX 2022003230A MX 2022003230 A MX2022003230 A MX 2022003230A MX 2022003230 A MX2022003230 A MX 2022003230A
Authority
MX
Mexico
Prior art keywords
antiperspirant compositions
compositions
antiperspirant
honokiol
capsaicin
Prior art date
Application number
MX2022003230A
Other languages
English (en)
Inventor
Richard Livesey Evans
Original Assignee
Unilever Ip Holdings B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Ip Holdings B V filed Critical Unilever Ip Holdings B V
Publication of MX2022003230A publication Critical patent/MX2022003230A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describen composiciones antitranspirantes naturales que comprenden benzaldehido, honokiol o capsaicina y su método de uso.
MX2022003230A 2019-09-20 2020-09-17 Composiciones antitranspirantes. MX2022003230A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19198703 2019-09-20
PCT/EP2020/076016 WO2021053093A1 (en) 2019-09-20 2020-09-17 Antiperspirant compositions

Publications (1)

Publication Number Publication Date
MX2022003230A true MX2022003230A (es) 2022-04-26

Family

ID=68062820

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022003230A MX2022003230A (es) 2019-09-20 2020-09-17 Composiciones antitranspirantes.

Country Status (6)

Country Link
US (1) US20220339093A1 (es)
EP (1) EP4031099B1 (es)
AU (2) AU2020349599A1 (es)
BR (1) BR112022004141A2 (es)
MX (1) MX2022003230A (es)
WO (1) WO2021053093A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023161264A1 (en) * 2022-02-23 2023-08-31 Prospera Biotech, S.L. Compositions for treating hyperhidrosis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792068A (en) 1971-04-02 1974-02-12 Procter & Gamble Dry powder aerosol antiperspirant composition incorporating dry powder antiperspirant active complex and process for its preparation
EP0006739B1 (en) 1978-06-23 1982-10-13 Unilever Plc Antiperspirant composition and methods for its preparation and use
DE69922273T2 (de) * 1998-02-03 2005-12-15 Firmenich S.A. Verwendung des 2,5,6-Trimethyl-2-heptanol als Riech- und Geschmacksstoff
GB0019055D0 (en) 2000-08-03 2000-09-27 Unilever Plc Antiperspirant and deodorant products and methods for their use
US20050142085A1 (en) * 2003-12-24 2005-06-30 Kao Corporation Antiperspirant and deodorant stick composition
EP1951186A4 (en) 2005-10-19 2009-11-04 Menni Menashe Zinger METHODS FOR TREATING HYPERHIDROSIS
AU2008314628B2 (en) 2007-10-18 2014-03-06 Rose U Topical glycopyrrolate formulations
WO2009087578A2 (en) * 2008-01-08 2009-07-16 Foamix Ltd. Sensation modifying topical composition foam
EP3168251B1 (de) * 2015-11-16 2019-02-06 Evonik Degussa GmbH Vernetzte polyglycerinester
CN108236646A (zh) * 2018-02-06 2018-07-03 贺建华 减肥水凝胶贴剂及其制备方法

Also Published As

Publication number Publication date
WO2021053093A1 (en) 2021-03-25
AU2020349599A1 (en) 2022-03-31
EP4031099B1 (en) 2023-03-01
US20220339093A1 (en) 2022-10-27
EP4031099A1 (en) 2022-07-27
BR112022004141A2 (pt) 2022-05-31
AU2024201823A1 (en) 2024-04-11

Similar Documents

Publication Publication Date Title
MX2021014441A (es) Inhibidores del dominio asociado mejorador de la transcripcion (tead) y usos de los mismos.
MX2021014443A (es) Inhibidores del dominio asociado mejorador de la transcripcion (tead) y usos de los mismos.
MX2020006812A (es) Degradadores de cinasas asociadas al receptor de interleucina-1 (irak) y usos de los mismos.
IL280963A (en) Anti-5gdf1 antibodies, compounds and methods of use
MX2022007576A (es) Degradadores de cinasas asociadas al receptor de interleucina-1 (irak) y usos de los mismos.
NZ742787A (en) Compositions comprising bacterial strains
MX2020007799A (es) Inhibidores de cinasa no derrepresible de control de aminoacido general 2 (gcn2) y sus usos.
MX2021012216A (es) Degradadores de transductores de señal y activadores de transcripción (stat) y usos de los mismos.
AU2016261707A8 (en) Use of cannabis to treat fibromyalgia, methods and compositions thereof
MX2018016038A (es) Compuestos y metodos para modular la funcion del acido ribonucleico (arn).
SG10201808835QA (en) Anti-siglec-8 antibodies and methods of use thereof
MX2020010951A (es) Anticuerpos anti-hla-g y utilizacion de los mismos.
PH12020551716A1 (en) Anti-ror antibody constructs
MX2019010984A (es) Composiciones de sintecina y metodos de uso.
MX2019010643A (es) Formas y composiciones de un inhibidor de proteina cinasa 2 activada por la proteina cinasa activada por mitogeno (mk2).
MX2022007841A (es) Degradadores del regulador dependiente de actina asociado a la matriz relacionado con el complejo switch/sacarosa no fermentable de la subfamilia a de la cromatina (smarca)y usos de los mismos.
PH12018502233A1 (en) ErbB INHIBITORS AND USES THEREOF
MX2021006977A (es) Anellosomas y metodos de uso.
MX2021014949A (es) Recubrimientos resistentes a la incrustación biológica y métodos para elaborar y usar los mismos.
MX2021008834A (es) Metodos de tratamiento del cancer de mama con tucatinib.
SG11202011227VA (en) Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof
IL289586A (en) pi4kiii alpha micromolecule inhibiting preparation, method for its preparation and use
IL285088A (en) The composition containing cannabinoids, methods for its preparation and uses
EP3790552A4 (en) COMBINATION COMPOSITIONS WITH BISFLUORAKYL-1,4-BENZODIAZEPINONE COMPOUNDS AND METHODS OF USE THERE
MX2022003230A (es) Composiciones antitranspirantes.